Crism Therapeutics Corporation Ord Npv (CRTX) RNS Announcements

Add to Alert list
Date Time Source Announcement
27 Nov 2025 07:00 AM
RNS
Holding(s) in Company
30 Oct 2025 07:00 AM
RNS
US Orphan Drug Designation Application
14 Oct 2025 07:00 AM
RNS
Positive Preclinical Data in Prostate Cancer
15 Sep 2025 07:00 AM
RNS
Half Year Report
12 Sep 2025 07:00 AM
RNS
Notice of Interim Results and IMC Presentation
01 Sep 2025 07:00 AM
RNS
Approval for phase 2 clinical trial
26 Aug 2025 04:03 PM
RNS
Result of AGM
26 Aug 2025 07:00 AM
RNS
AGM Statement
12 Aug 2025 07:00 AM
RNS
GMP Manufacture of ChemoSeed
04 Aug 2025 05:45 PM
RNS
Notice of AGM and EMI Option Plan
10 Jul 2025 03:04 PM
RNS
Holding(s) in Company
03 Jul 2025 07:00 AM
RNS
Result of Retail Offer and Additional Placing
01 Jul 2025 04:41 PM
RNS
Update presentation on the IMC platform
01 Jul 2025 07:00 AM
RNS
Submission of CTA Application
30 Jun 2025 07:01 AM
RNS
Retail Offer
30 Jun 2025 07:00 AM
RNS
Placing
13 Jun 2025 07:00 AM
RNS
Final Results for the year ended 31 December 2024
09 Jun 2025 07:00 AM
RNS
Best Paper Award
03 Jun 2025 07:00 AM
RNS
Establishment of Scientific Advisory Board
07 Apr 2025 11:46 AM
RNS
Director Dealing
31 Mar 2025 07:00 AM
RNS
Clinical Trial Update
27 Mar 2025 07:00 AM
RNS
Innovate UK Grant Award
20 Dec 2024 07:00 AM
RNS
Appointment of Specialist Clinical CRO
18 Dec 2024 07:00 AM
RNS
European Patent Grant
19 Sep 2024 07:00 AM
RNS
Interim Results
09 Sep 2024 07:00 AM
RNS
Notice of Interim Results & IMC Presentation
03 Sep 2024 07:00 AM
RNS
Delivery Method Validated in Peer Reviewed Journal
02 Sep 2024 07:00 AM
RNS
Innovation Passport Award
30 Jul 2024 07:00 AM
RNS
CRISM Signs Service Agreement Contract
03 Jul 2024 04:18 PM
RNS
Response to Movement in Share Price
03 Jun 2024 03:25 PM
RNS
Director Dealing
UK 100

Latest directors dealings